Showing results (91-100 of 141) with videos related to
Sort By:
Pageof 15
The American Surgeon|June 3, 2014
Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessmentScott R Steele, Anton Bilchik, Eric K Johnson, et al.Journal of the American Academy of Dermatology|January 20, 2020
Quantitative metastatic lymph node burden and survival in Merkel cell carcinomaAnthony T Nguyen, Michael Luu, Diana J Lu, et al.Journal of the American College of Surgeons|July 3, 2017
Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous MelanomaDaniel W Nelson, Stacey Stern, David E Elashoff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestineFarin F Amersi, Alicia M Terando, Yasufumi Goto, et al.Journal of the American College of Surgeons|May 30, 2016
Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in MelanomaDavid Y Lee, Briana J Lau, Kelly T Huynh, et al.Annals of Surgical Oncology|July 1, 2015
Attitudes and Perceptions of Surgical Oncology Fellows on ACGME Accreditation and the Complex General Surgical Oncology CertificationDavid Y Lee, Devin C Flaherty, Briana J Lau, et al.JAMA Surgery|September 1, 2021
Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous MelanomaAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.JAMA Network Open|February 6, 2024
Smoking Status and Survival in Patients With Early-Stage Primary Cutaneous MelanomaKatherine M Jackson, Peter C Jones, Laura M Fluke, et al.Annals of Surgery|December 29, 2011
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanomaSojun Hoshimoto, Mark B Faries, Donald L Morton, et al.Frontiers in Oncology|June 7, 2014
Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 LevelsAnna M Leung, Agnes Fermin Lee, Junko Ozao-Choy, et al.Pageof 15